Question 1

What is the catalog number for [1,3]Thiazolo[5,4-b]pyridine-5-carboxylic acid?

Accepted Answer

The catalog number for [1,3]Thiazolo[5,4-b]pyridine-5-carboxylic acid is OR305434.

Question 2

What sizes are available for [1,3]Thiazolo[5,4-b]pyridine-5-carboxylic acid?

Accepted Answer

[1,3]Thiazolo[5,4-b]pyridine-5-carboxylic acid is available in the following size(s): 250 mg, 1 g.

Question 3

How many pack sizes does [1,3]Thiazolo[5,4-b]pyridine-5-carboxylic acid come in?

Accepted Answer

[1,3]Thiazolo[5,4-b]pyridine-5-carboxylic acid is available in 2 different pack sizes.

Question 4

Is [1,3]Thiazolo[5,4-b]pyridine-5-carboxylic acid in stock?

Accepted Answer

[1,3]Thiazolo[5,4-b]pyridine-5-carboxylic acid is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 6

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 7

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

[1,3]Thiazolo[5,4-b]pyridine-5-carboxylic acid

Product Specifications

CAS Number

MDL Number

Purity

Smiles

Available Sizes

Frequently Asked Questions

Explore Other Products

Anti-RANK/TNFRSF11A Antibody Picoband® (Dylight550 Conjugate)

Anti-DRG1 Antibody Picoband®

PMEPA1 / TMEPAI (Tumor Suppressor Oncoprotein) (PMEPA1/2696), CF647 conjugate, 0.1mg/mL

Involucrin (IVRN/827), CF405S conjugate, 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (NAPSA/3306), CF405S conjugate, 0.1mg/mL

RET Proto-oncogene (RET/2662), 1mg/mL